Ramiprilat is the active metabolite of the angiotensin-converting enzyme (ACE) inhibitor Ramipril, featuring a tetrahydrofuran ring fused to a dipeptide-like structure with a terminal carboxylic acid group. Its core structure includes a hydrophobic isobutyl substituent and a proline-derived pyrrolidine moiety, critical for ACE inhibition. The compound lacks the ester prodrug functionality of Ramipril, existing as the pharmacologically active form generated via hepatic hydrolysis. It serves as an HPLC reference standard for quantifying Ramipril degradation products in stability studies.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| EP | R0145000 ↗ | 10 MG | EUR 90.00 |
| USP | 1598303 ↗ | 125 mg | USD 297.00 |
CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2[C@H]3CCC[C@H]3C[C@H]2C(=O)O
InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1
HDACQVRGBOVJII-JBDAPHQKSA-N